The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness

ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy

(2020) Ya‐Ru Miao et al.   Advanced Science

In silico analysis of the immunological landscape of pituitary adenomas

(2020) Jacky T. Yeung et al.   JOURNAL OF NEURO-ONCOLOGY

Immunotherapy and potential molecular targets for the treatment of pituitary adenomas resistant to standard therapy: a critical review of potential therapeutic targets and current developments

(2020) Tamara Maghathe et al.   Journal of Neurosurgical Sciences

Acromegaly

(2019) Annamaria Colao et al.   Nature Reviews Disease Primers

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature

(2019) Xuanwen Bao et al.   Frontiers in Oncology

Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab

(2019) Mario Caccese et al.   ANTI-CANCER DRUGS

Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease

(2019) Hanna R Kemeny et al.   CLINICAL CANCER RESEARCH

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

(2019) Pedro Marques et al.   Acta Neuropathologica Communications

The Role of Aberrant DNA Methylation in Misregulation of Gene Expression in Gonadotroph Nonfunctioning Pituitary Tumors

(2019) Paulina Kober et al.   Cancers

Pangenomic Classification of Pituitary Neuroendocrine Tumors

(2019) Mario Neou et al.   CANCER CELL

USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status

(2019) Mateusz Bujko et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Quality of Life in Patients With Cushing's Disease

(2019) Alicia Santos et al.   Frontiers in Endocrinology

Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis

(2018) Reem D. Almutairi et al.   ACTA NEUROCHIRURGICA

The Immune Landscape of Cancer

(2018) Vésteinn Thorsson et al.   IMMUNITY

The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy

(2018) Peng-fei Wang et al.   JOURNAL OF NEURO-ONCOLOGY

Gene expression profiling in human corticotrope tumors reveals distinct, neuroendocrine profiles

(2018) Maria Francesca Cassarino et al.   JOURNAL OF NEUROENDOCRINOLOGY

Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms

(2018) Marco Bezzi et al.   NATURE MEDICINE

Mortality in patients with non-functioning pituitary adenoma

(2018) Metaxia Tampourlou et al.   Pituitary

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry

(2018) Veronica D. Gonzalez et al.   Cell Reports

Immune Microenvironment in Glioblastoma Subtypes

(2018) Zhihong Chen et al.   Frontiers in Immunology

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

(2018) Judith A. Seidel et al.   Frontiers in Oncology

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

(2018) Leeat Keren et al.   CELL

Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab

(2018) Andrew L Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges

(2018) Jingjing Duan et al.   Cancer Medicine

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

(2018) Moshe Sade-Feldman et al.   CELL

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

(2017) Gerald Raverot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Diagnosis and Treatment of Pituitary Adenomas

(2017) Mark E. Molitch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

(2017) Julien Racle et al.   eLife

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma

(2017) Bangrong Cao et al.   OncoImmunology

Tumor infiltrating immune cells in gliomas and meningiomas

(2016) Patrícia Domingues et al.   BRAIN BEHAVIOR AND IMMUNITY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

(2016) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Refractory pituitary adenoma: a novel classification for pituitary tumors

(2016) Congxin Dai et al.   Oncotarget

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

(2016) Yu Mei et al.   Oncotarget

Recurrent gain-of-function USP8 mutations in Cushing's disease

(2015) Zeng-Yi Ma et al.   CELL RESEARCH

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas

(2015) Jian-Qiang Lu et al.   ENDOCRINE PATHOLOGY

The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells

(2015) Almut Dufner et al.   NATURE IMMUNOLOGY

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery

(2013) Tove Lekva et al.   PLoS One

CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells

(2013) Yanmeng Peng et al.   PLoS One

Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis

(2012) M. Ammirati et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Identification of Growth Arrest and DNA-Damage-Inducible Gene β (GADD45β) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors

(2011) Katherine A. Michaelis et al.   ENDOCRINOLOGY

Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

(2011) O. S. Qureshi et al.   SCIENCE

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

(2010) Matthew D. Wilkerson et al.   BIOINFORMATICS

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endoscopic pituitary surgery: a systematic review and meta-analysis

(2009) Abtin Tabaee et al.   JOURNAL OF NEUROSURGERY